[{"id":"e1f4b5d9-cd5a-47dd-995e-7ea37a995e84","acronym":"","url":"https://clinicaltrials.gov/study/NCT05464836","created_at":"2022-07-19T14:54:34.934Z","updated_at":"2024-07-02T16:35:19.865Z","phase":"Phase 2","brief_title":"Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL","source_id_and_acronym":"NCT05464836","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" BCL2 • CD8 • CD34 • CD5 • CD7 • CD2","pipe":"","alterations":" ","tags":["BCL2 • CD8 • CD34 • CD5 • CD7 • CD2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Venclexta (venetoclax) • limantrafin (CB-103)"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 04/06/2023","start_date":" 04/06/2023","primary_txt":" Primary completion: 07/01/2026","primary_completion_date":" 07/01/2026","study_txt":" Completion: 07/01/2026","study_completion_date":" 07/01/2026","last_update_posted":"2024-02-12"},{"id":"c03cd6cf-6527-4a1c-bcb8-a257d0066911","acronym":"","url":"https://clinicaltrials.gov/study/NCT03031691","created_at":"2021-01-18T14:55:19.151Z","updated_at":"2024-07-02T16:36:42.138Z","phase":"Phase 1b","brief_title":"A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer","source_id_and_acronym":"NCT03031691","lead_sponsor":"OncoMed Pharmaceuticals, Inc.","biomarkers":" KRAS","pipe":" | ","alterations":" KRAS wild-type • RAS wild-type","tags":["KRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS wild-type • RAS wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Lonsurf (trifluridine/tipiracil) • brontictuzumab (OMP-52M51)"],"overall_status":"Completed","enrollment":" Enrollment 7","initiation":"Initiation: 01/01/2017","start_date":" 01/01/2017","primary_txt":" Primary completion: 05/01/2017","primary_completion_date":" 05/01/2017","study_txt":" Completion: 09/01/2017","study_completion_date":" 09/01/2017","last_update_posted":"2020-08-11"},{"id":"35ab7548-637e-4229-8bfc-9998c89fa4e2","acronym":"","url":"https://clinicaltrials.gov/study/NCT01653470","created_at":"2021-01-18T07:07:38.583Z","updated_at":"2024-07-02T16:36:50.836Z","phase":"Phase 1","brief_title":"Study to Evaluate Safety \u0026 Tolerability of BMS-906024 in Combination With Chemotherapy \u0026 to Define DLTs \u0026 MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors","source_id_and_acronym":"NCT01653470","lead_sponsor":"Bristol-Myers Squibb","biomarkers":" HES1","pipe":" | ","alterations":" NOTCH mutation","tags":["HES1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NOTCH mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e carboplatin • paclitaxel • 5-fluorouracil • irinotecan • leucovorin calcium • AL101 • fluorouracil topical"],"overall_status":"Completed","enrollment":" Enrollment 141","initiation":"Initiation: 10/12/2012","start_date":" 10/12/2012","primary_txt":" Primary completion: 05/03/2017","primary_completion_date":" 05/03/2017","study_txt":" Completion: 05/08/2017","study_completion_date":" 05/08/2017","last_update_posted":"2020-01-28"},{"id":"ffc3eeaf-0c0b-4248-ac40-a4e3ffc99220","acronym":"","url":"https://clinicaltrials.gov/study/NCT02518113","created_at":"2021-01-18T12:10:07.428Z","updated_at":"2024-07-02T16:36:55.784Z","phase":"Phase 1b","brief_title":"A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL","source_id_and_acronym":"NCT02518113","lead_sponsor":"Eli Lilly and Company","biomarkers":" NOTCH1 • FBXW7","pipe":" | ","alterations":" FBXW7 mutation • NOTCH mutation","tags":["NOTCH1 • FBXW7"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FBXW7 mutation • NOTCH mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e dexamethasone • crenigacestat (LY3039478)"],"overall_status":"Completed","enrollment":" Enrollment 36","initiation":"Initiation: 10/01/2015","start_date":" 10/01/2015","primary_txt":" Primary completion: 01/15/2018","primary_completion_date":" 01/15/2018","study_txt":" Completion: 01/15/2018","study_completion_date":" 01/15/2018","last_update_posted":"2019-09-11"},{"id":"b9bd979a-e4a6-4642-b91a-5eb322a28447","acronym":"","url":"https://clinicaltrials.gov/study/NCT00756717","created_at":"2021-01-18T02:51:35.116Z","updated_at":"2025-02-25T15:58:33.556Z","phase":"Phase 4","brief_title":"Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer","source_id_and_acronym":"NCT00756717","lead_sponsor":"Loyola University","biomarkers":" ER","pipe":" | ","alterations":" ER positive","tags":["ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e tamoxifen • letrozole • MK-0752"],"overall_status":"Completed","enrollment":" Enrollment 22","initiation":"Initiation: 02/14/2008","start_date":" 02/14/2008","primary_txt":" Primary completion: 12/21/2011","primary_completion_date":" 12/21/2011","study_txt":" Completion: 12/21/2011","study_completion_date":" 12/21/2011","last_update_posted":"2019-09-04"},{"id":"c4c82fe3-fb0f-463e-9f2b-c75e3ed45026","acronym":"","url":"https://clinicaltrials.gov/study/NCT01175343","created_at":"2021-01-18T04:41:25.819Z","updated_at":"2024-07-02T16:37:21.804Z","phase":"Phase 2","brief_title":"RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer","source_id_and_acronym":"NCT01175343","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" MUC16","pipe":" | ","alterations":" MUC16 elevation","tags":["MUC16"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MUC16 elevation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e RG4733"],"overall_status":"Completed","enrollment":" Enrollment 45","initiation":"Initiation: 07/01/2010","start_date":" 07/01/2010","primary_txt":" Primary completion: 10/01/2012","primary_completion_date":" 10/01/2012","study_txt":" Completion: 08/01/2015","study_completion_date":" 08/01/2015","last_update_posted":"2017-05-24"}]